Candel Therapeutics, Inc. (CADL)

NASDAQ: CADL · IEX Real-Time Price · USD

9.02

+0.59 (7.00%)

At close: May 3, 2024, 4:00 PM

8.90

-0.12 (-1.33%)

After-hours: May 3, 2024, 7:59 PM EDT

Candel Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Net Income	-37.94	-18.79	-36.12	-17.68	-8.24
Depreciation & Amortization	1.2	0.99	0.23	0.09	0.04
Share-Based Compensation	3.09	2.31	2.96	2.11	0.4
Other Operating Activities	-0.6	-15.92	10.71	6.41	2.62
Operating Cash Flow	-34.24	-31.42	-22.22	-9.07	-5.18
Capital Expenditures	-0.28	-1.3	-1.84	-1.48	-0.16
Acquisitions	0	0	0	0	-0.85
Change in Investments	0	0	0	39.93	-34.74
Investing Cash Flow	-0.28	-1.3	-1.84	38.46	-35.74
Share Issuance / Repurchase	0	0.06	71.8	0.03	0
Debt Issued / Paid	0	19.91	0	0.46	-0.52
Other Financing Activities	-0.12	-	-	-	22.5
Financing Cash Flow	-0.12	19.97	71.8	0.49	21.98
Net Cash Flow	-34.65	-12.74	47.75	29.87	-18.94
Free Cash Flow	-34.52	-32.72	-24.05	-10.55	-5.34
Free Cash Flow Per Share	-1.19	-1.14	-1.27	-0.91	-0.46

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).